artenimol has been researched along with Carcinoma, Ductal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Habibi, Z; Hassan, ZM; Noori, S; Rezaei, B; Taghikhani, M | 1 |
1 other study(ies) available for artenimol and Carcinoma, Ductal
Article | Year |
---|---|
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses.
Topics: Animals; Antineoplastic Agents; Artemisinins; Calmodulin; Carcinoma, Ductal; Cyclic Nucleotide Phosphodiesterases, Type 1; Erythrocytes; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C | 2010 |